欧美人妻精品区三区|无码免费特级毛片|久久伊人中文无码|亚洲欧洲免费在线播放

<optgroup id="khvqs"><em id="khvqs"></em></optgroup>
    1. <span id="khvqs"><sup id="khvqs"></sup></span>
      <optgroup id="khvqs"></optgroup>
      <acronym id="khvqs"><sup id="khvqs"></sup></acronym>

      <track id="khvqs"><i id="khvqs"></i></track>
    2. 當前位置: 首頁 » 資訊 » 圖片新聞 » 正文

      Felypressin生物活性及實驗方法參考

      發(fā)布日期:2017-12-05   瀏覽次數(shù):0
      核心提示:產(chǎn)品名稱:a href=http://www.medchemexpress.cn/Felypressin.htmlFelypressin/a__Felypressin是Vasopressin 1激動劑,能夠影響
      產(chǎn)品名稱:Felypressin__Felypressin是Vasopressin 1激動劑,能夠影響精氨酸所有的vasopressin receptor 1As。
      產(chǎn)品研究領域:OthersOthers
      Felypressin相關產(chǎn)品SBE-β-CD  |  MPTP hydrochloride  |  Cyclosporin A  |  Etomoxir  |  Auranofin  |  GKT137831  |  Ceruletide  |  Acetylcysteine  |  JC-1  |  BPTES  |  Brassinolide  |  FCCP  |  IPTG  |  MTT  |  RSL3 1S,3R-  |  
      產(chǎn)品生物活性:Description
                                                                   Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As.target: Vasopressin 1 agonist;Felypressin is a synthetic hormone of the posterior pituitary lobe characterized by vasoconstrictor properties that is widely used in dental procedures.Felypressin has been widely added to local anesthetic solutions to increase the duration of the anesthetic effect and reduce the risk of toxicity during dental procedures.
                                                         
                                                                                                                                                                          References
      [1]. Bronzo AL et al. Felypressin increases blood pressure during dental procedures in hypertensive patients. Arq Bras Cardiol. 2012 Aug;99(2):724-31.
                                                                      [2]. Cecanho R et al. Cardiovascular effects of felypressin. Anesth Prog. 2006 Winter;53(4):119-25.
      公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領域的一流供應商, 產(chǎn)品涵蓋癌癥、神經(jīng)科學、抗感染、表觀遺傳學等20個熱門研究領域4545K、MAPK等近千個細分靶點,中文http://www.medchemexpress.cn
       
       
       
      ?